Skip to main content

Nathaniel S. Gardiner

Equibles does not estimate personal net worth.

Get an email with a short summary when Enanta Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get ENTA alerts

About Nathaniel S. Gardiner

Nathaniel S. Gardiner is recorded as General Counsel at Enanta Pharmaceuticals Inc (ENTA). The newest filing on record that lists Nathaniel S. Gardiner as General Counsel at Enanta Pharmaceuticals Inc (ENTA) is dated January 20, 2023. The proxy statement of Enanta Pharmaceuticals Inc reports total compensation of $2,855,081 for Nathaniel S. Gardiner in fiscal 2023, including a base salary of $475,275. Disclosed compensation is on record for 7 fiscal years. Enanta Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Enanta Pharmaceuticals Inc includes Harry R. Trout, III (CFO), Paul Mellett (CFO), Tara L. Kieffer, Ph.D. (COO) and 4 others.

Affiliation history

Company network

Leadership on record at Enanta Pharmaceuticals Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Enanta Pharmaceuticals Inc (ENTA) $475,275 $2,855,081
2022 Enanta Pharmaceuticals Inc (ENTA) $458,050 $2,382,727
2021 Enanta Pharmaceuticals Inc (ENTA) $444,675 $1,897,763
2020 Enanta Pharmaceuticals Inc (ENTA) $431,025 $1,788,991
2019 Enanta Pharmaceuticals Inc (ENTA) $398,850 $1,370,187
2018 Enanta Pharmaceuticals Inc (ENTA) $368,100 $1,509,516
2017 Enanta Pharmaceuticals Inc (ENTA) $368,100 $1,509,516

Recent activity

No call appearances or filed executive changes recorded yet.